Retrospective analysis of efficacy and safety of Gemcitabine-based chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOX

BACKGROUND: Metastatic pancreatic adenocarcinoma (MPA) represents a highly lethal condition. Despite the improvements seen with FOLFIRINOX, there is no randomized data to guide treatment selection beyond this regimen. We aimed to evaluate the outcomes of patients with MPA progressing on FOLFIRINOX w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastrointest Oncol
Autors principals: de Jesus, Victor Hugo Fonseca, Camandaroba, Marcos Pedro Guedes, Donadio, Mauro Daniel Spina, Cabral, Audrey, Muniz, Thiago Pimentel, de Moura Leite, Luciana, Sant’Ana, Lucas Ferreira
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6219982/
https://ncbi.nlm.nih.gov/pubmed/30505579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.06.08
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars